Treatment Options for Postherpetic Neuralgia
First-line pharmacological treatments for postherpetic neuralgia include gabapentin, pregabalin, and 5% lidocaine patches, with gabapentin recommended as the primary systemic option starting at 300 mg on day 1 and titrating to 1800-2400 mg/day in divided doses. 1
First-Line Pharmacological Options
Gabapentin
- Dosing regimen:
- Efficacy: Demonstrated in multiple randomized controlled trials with 50% or greater reduction in pain scores 2, 3
- Special considerations:
Pregabalin
- Dosing regimen:
- Efficacy: FDA-approved for PHN with demonstrated efficacy in placebo-controlled trials 4
- Special considerations:
5% Lidocaine Patch
- Dosing regimen:
- Apply up to 3 patches to cover the painful area for 12 hours per day, with patches removed for the remaining 12 hours 1
- Mechanism: Blocks sodium ion channels required for neuronal impulses, providing targeted pain relief with minimal systemic absorption 1
- Advantages:
- Particularly effective for localized pain areas
- Minimal systemic side effects
- Can be used in combination with systemic therapies 1
Second-Line and Adjunctive Treatments
High-Concentration Capsaicin
- Provides pain relief for at least 12 weeks
- Pre-treatment with 4% lidocaine for 60 minutes recommended to reduce application discomfort 1
Interventional Options for Refractory Cases
- Pulsed radiofrequency (PRF) targeting the dorsal root ganglion - effective with long-term efficacy 1
- Botulinum toxin A injections:
- Dosing: 50-100 units divided across affected dermatomes
- Advantage: minimal side effects with 3-4 months duration of effect 1
- Stellate ganglion block:
- Priority if PHN duration is less than 1 year
- Success rate: 75% improvement if used within 1 year vs. 44% if used after 1 year 1
- Neuromodulation options for highly refractory cases:
- Spinal cord stimulation
- Peripheral nerve stimulation 1
Non-Pharmacological Interventions
Transcutaneous electrical nerve stimulation (TENS):
- Non-invasive option with electrodes placed in or around the painful area
- No serious adverse effects and can be used at home 1
Cognitive Behavioral Therapy (CBT):
- Helps address maladaptive behaviors related to pain 1
Physical Therapy:
- Recommended for chronic pain management 1
Combination Therapy Approach
For patients with refractory pain, multimodal approaches may be more effective:
- Lidocaine patches can be combined with gabapentin, pregabalin, or tricyclic antidepressants 1
- Combination therapy (e.g., PRF + nerve block) may be more effective than monotherapy 1
Special Considerations
Elderly Patients
- Start at lower doses and titrate more slowly
- Increased risk of adverse effects, particularly with tricyclic antidepressants 1
Renal Impairment
- Both gabapentin and pregabalin require dose adjustment based on creatinine clearance 1, 2
- For gabapentin in patients with creatinine clearance 30-59 mL/min: 400-1400 mg/day in divided doses
- For patients with creatinine clearance 15-29 mL/min: 200-700 mg/day 2
Prevention
- Antiviral therapy started within 72 hours of rash onset reduces acute pain and risk of PHN
- Oral acyclovir, famciclovir, or valacyclovir recommended
- Immunocompromised patients may require intravenous antiviral therapy 1
Treatment Algorithm
- First-line: Start with gabapentin (titrate as tolerated) OR 5% lidocaine patch for localized pain
- If inadequate response after 4-6 weeks: Switch to pregabalin OR add lidocaine patch to systemic therapy
- If still inadequate: Consider interventional options based on duration of PHN
- For all patients: Consider adjunctive non-pharmacological approaches